ZSWIM1 inhibitors are a class of chemical compounds designed to specifically target the ZSWIM1 protein, which belongs to the zinc finger SWIM-type domain-containing family. ZSWIM1 is known to be involved in protein-protein interactions, often acting as a scaffold or regulator within cellular pathways. The SWIM domain, a conserved motif found in proteins that are implicated in ubiquitin-related processes, allows ZSWIM1 to interact with other proteins involved in the ubiquitination machinery, which is critical for the degradation of proteins via the proteasome. Inhibitors of ZSWIM1 disrupt its function, potentially altering ubiquitin signaling or interfering with its interactions with key regulatory proteins. This disruption may have downstream effects on protein stability and degradation, impacting various cellular processes dependent on protein turnover.
By inhibiting ZSWIM1, these compounds could affect the regulation of proteins targeted for ubiquitination, particularly those involved in cell cycle regulation, DNA repair, or stress responses. ZSWIM1 is believed to participate in pathways that ensure the proper tagging of proteins with ubiquitin, marking them for degradation or altering their activity within the cell. Blocking ZSWIM1 function with specific inhibitors may impair these processes, leading to the accumulation of proteins that are normally degraded or a failure to regulate proteins that require modification. This interference provides researchers with a valuable tool to investigate the precise role of ZSWIM1 in ubiquitination pathways and its broader impact on cellular homeostasis. Through the use of ZSWIM1 inhibitors, it is possible to explore the molecular mechanisms underlying protein regulation and the intricate balance maintained by ubiquitin signaling in cells.
SEE ALSO...
Items 1 to 10 of 24 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor, could affect ubiquitination and degradation processes involving ZSWIM1. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which enhances ZSWIM1 by promoting PKA activation, possibly influencing gene expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid binds retinoic acid receptors, affecting gene transcription, which may upregulate ZSWIM1 expression through genomic signaling pathways. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor, potentially impacting protein degradation pathways relevant to ZSWIM1. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Vitamin D3 through its active metabolite, calcitriol, binds VDR, potentially influencing the expression of ZSWIM1 by modulating gene transcription. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
Specific proteasome inhibitor, may influence protein turnover related to ZSWIM1's function. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
Inhibits ubiquitin-activating enzyme E1, potentially affecting ubiquitination processes involving ZSWIM1. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that can enhance chromatin accessibility, possibly leading to increased ZSWIM1 transcription. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
Inhibits NEDD8-activating enzyme, affecting neddylation, a process related to ubiquitination that could influence ZSWIM1. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
As a DNA methyltransferase inhibitor, it reduces DNA methylation, potentially leading to the demethylation and activation of the ZSWIM1 gene. | ||||||